Novel and Emerging Therapies in Renal Cell Carcinoma
Novel and Emerging Therapies in Renal Cell Carcinoma is organized by Prime Education, LLC.
Release Date: April 26, 2023
Expiration Date: April 25, 2024
Description:
New and emerging immuno-oncology and targeted therapies are contributing to a rapidly evolving treatment landscape in renal cell carcinoma. Join us for this on-demand Learning Lab activity for expert discussion on novel and emerging therapies, the latest clinical evidence, and guideline recommendations for the treatment of renal cell carcinoma.
This activity is part of a series; case managers must complete all 4 activities in this learning lab before reporting credit to the Commission for Case Manager Certification using the activity code and approval number issued upon completion.
Agenda:
• Review of Complex Mechanisms of Action and Molecular Targets of Novel Therapies
• Overview of Latest Clinical Evidence of Novel and Emerging Therapies in RCC
Learning Objectives:
• Differentiate available and emerging therapies for advanced renal cell carcinoma (RCC) based on mechanism of action, indication, placement in treatment, safety, and efficacy
• Apply current evidence to individualize treatment decision-making and sequencing of therapies for patients with advanced/metastatic RCC